The Class II directors, Thomas D. Kiley, Esq. and Edward V. Fritzky, have two years remaining on their term of office.
...Edward V. Fritzky
...Edward V. Fritzky has served as a director of the Company since July 1998.He currently serves as a director and advisor to Amgen Corporation.He served as Chief Executive Officer and Chairman of Immunex Corporation from January 1994 to July 2002.Mr. Fritzky is also a director of Sonosite, Inc. and Jacobs Engineering Group, Inc.Mr. Fritzky served as President of Lederle Laboratories, a division of American Cyanamid, from 1992 to 1994, and as Vice President of Lederle Laboratories from 1989 to 1992.Prior to joining Lederle Laboratories, Mr. Fritzky was an executive of Searle Pharmaceuticals, Inc., a subsidiary of the Monsanto Company.During his tenure at Searle, Mr. Fritzky was Vice President of Marketing in the United States, and later President and General Manager of Searle Canada, Inc. and Lorex Pharmaceuticals, a joint venture company.Mr. Fritzky holds a B.A. from Duquesne University and is a graduate of the Advanced Executive Program, J.L. Kellogg Graduate School of Management at Northwestern University.
, Kiley and Walker, met seven times in 2004 and acted by written consent on two occasions.
The members of the Nominating Committee
are Dr. Barkas and Mr. Fritzky